BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28437679)

  • 1. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
    Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
    Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
    Cerra-Franco A; Diab K; Lautenschlaeger T
    Expert Rev Anticancer Ther; 2016 Aug; 16(8):869-75. PubMed ID: 27279087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
    Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
    Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.
    Robson JM; Vaidyanathan S; Cheyne L; Snee M; Franks K; Callister ME
    Clin Lung Cancer; 2014 Nov; 15(6):466-9. PubMed ID: 25220208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
    Verma V; Schonewolf CA; Cushman TR; Post CM; Doms A; Berman AT; DeVries M; Katz SI; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):502-510. PubMed ID: 30111509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer - Results from a Single Institution Study.
    George B; Baydoun A; Bhat S; Bailey L; Arsenault T; Sun Y; Zhang Y; Zheng Y; Vempati P; Podder T; Biswas T
    Clin Lung Cancer; 2024 Jun; 25(4):e181-e188. PubMed ID: 38553326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC.
    Kennedy WR; Samson PP; Gabani P; Nikitas J; Bradley JD; Roach MC; Robinson CG
    Radiother Oncol; 2020 Sep; 150():206-210. PubMed ID: 32622780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
    Vial MR; Khan KA; O'Connell O; Peng SA; Gomez DR; Chang JY; Rice DC; Mehran R; Jimenez CJ; Grosu HB; Ost DE; Eapen GA
    Ann Thorac Surg; 2017 May; 103(5):1600-1605. PubMed ID: 28027732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal recurrences after stereotactic body radiotherapy for early stage non-small-cell lung cancer.
    Tibdewal A; Pathak RS; Agarwal JP; Hoskote SS; Mummudi N; Iyer V; Nair AG
    Curr Probl Cancer; 2021 Apr; 45(2):100653. PubMed ID: 32988628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
    Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA
    Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
    Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
    Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
    Wink KCJ; Löck S; Rossi M; van Baardwijk A; Belderbos J; de Ruysscher D; Troost EGC
    Radiother Oncol; 2019 Feb; 131():120-126. PubMed ID: 30773178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
    Giuliani ME; Hope A; Mangona V; Guckenberger M; Mantel F; Peulen H; Sonke JJ; Belderbos J; Werner-Wasik M; Ye H; Grills IS
    Clin Lung Cancer; 2017 Mar; 18(2):162-168. PubMed ID: 27876604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists.
    Febbo JA; Gaddikeri RS; Shah PN
    Radiographics; 2018; 38(5):1312-1336. PubMed ID: 30074857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SBRT for centrally localized NSCLC - What is too central?
    Roesch J; Panje C; Sterzing F; Mantel F; Nestle U; Andratschke N; Guckenberger M
    Radiat Oncol; 2016 Dec; 11(1):157. PubMed ID: 27912764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.
    Manabe Y; Shibamoto Y; Baba F; Yanagi T; Iwata H; Miyakawa A; Murai T; Okuda K
    Jpn J Radiol; 2018 Dec; 36(12):719-725. PubMed ID: 30218253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
    Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
    Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
    Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
    J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
    Marwaha G; Stephans KL; Woody NM; Reddy CA; Videtic GM
    J Thorac Oncol; 2014 Nov; 9(11):1693-7. PubMed ID: 25185531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
    Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
    Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.